The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ESPERION THERAPEUTICS INC NE COMMON 29664W105 53,244 1,200,000 SH   DFND 1 0 0 1,200,000
ESPERION THERAPEUTICS INC NE COMMON 29664W105 4 100 SH   DFND   0 0 100
INSEEGO CORP NOTE 5.500% 6/1 45782BAA2 11,222 13,700,000 PRN   DFND   0 0 13,700,000
INSEEGO CORP COMMON 45782B104 34,829 9,046,500 SH   DFND   0 0 9,046,500
MACROGENICS INC. COMMON 556099109 14,253 664,785 SH   DFND 1 0 0 664,785
MEDICINES CO COMMON 584688105 21,040 703,440 SH   DFND 1 0 0 703,440
MEDICINES CO COMMON 584688105 91,979 3,075,202 SH   DFND 2 0 0 3,075,202
MEDICINES CO COMMON 584688105 3 100 SH   DFND   0 0 100
MIRATI THERAPEUTICS INC COMMON 60468T105 147,704 3,135,966 SH   DFND 1 0 0 3,135,966
SOLID BIOSCIENCES INC. COMMON 83422E105 542 11,488 SH   DFND 1 0 0 11,488